-
Ischemic stroke in a Swedish case-control study.
Study
EGAS00001000936
-
We evaluate the potential for routine WGS using ONT by sequencing the well-characterised reference sample NA12878 and the genome of an individual with ataxia-pancytopenia syndrome accompanied by severe immune dysregulation.
Study
EGAS00001003469
-
Post_Mortem_Tissue_COVID19_RNA
Study
EGAS00001004442
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Prenatal lead exposure is associated with decreased cord blood DNA methylation of the glycoprotein VI gene involved in platelet activation and thrombus formation
Study
EGAS00001001575
-
UK10K NEURO UKSCZ
Study
EGAS00001000123
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Induced Pluripotent Cells Derived from Differentiated Rod Photoreceptors Undergo Efficient Retinogenesis in Three-Dimensional Cultures
Study
EGAS00001001288
-
A reference map of potential determinants for the human serum metabolome
Study
EGAS00001004512
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency
Study
EGAS00001000149
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
Circulating Tumor DNA in Checkpoint Inhibitor treated Lung Cancer
Study
EGAS00001004847
-
Characterization of a human iPSC-derived endocrine pancreas model
Study
EGAS00001001803
-
18 Whole Exome Sequencing for Radiation Induced-Meningiomas
Study
EGAS00001002317
-
Breast cancer women lack normal lifelong immune response after full-term pregnancies
Study
EGAS00001002616
-
DSRCT RNA genomic sequencing
Study
EGAS00001002770
-
Accurate detection and classification of pediatric sarcomas based on cell-free DNA fragmentation patterns
Study
EGAS00001005127
-
Genetic diversity and continuity of the population of the UAE
Study
EGAS00001004362
-
Matching of actionable mutations with therapies in cancer patients: comparison of three commercial decision support platforms
Study
EGAS00001004383
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
Post_Mortem_Tissue_COVID19_spatial
Study
EGAS00001004441
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
An analysis of humoral and cellular immune responses following COVID-19 vaccination.
Study
EGAS00001005380
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
IMCISION DNAseq
Study
EGAS00001005466
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Persistence of circulating tumor DNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumor response
Study
EGAS00001005798
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Genetics and therapeutic responses to TIL therapy of pancreatic cancer PDX models
Study
EGAS00001005596
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Monocyte and macrophage lipid accumulation results in downregulated type-I interferon responses
Study
EGAS00001005955
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Profiling the unique protective properties of intracranial arterial endothelial cells
Study
EGAS00001004479
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537